ThreoTech: Patent Dispute Ends
ThreoTech settles patent infringement dispute of involving magnesium L-Threonate
ThreoTech, LLC has entered a confidential settlement with doTerra, ending it’s patent infringement dispute involving Magtein magnesium L-threonate.
“Magtein is a unique dietary supplement ingredient protected by a variety of composition and use patents,” said Edward Lee, CEO of ThreoTech, LLC. “Our patent portfolio and other intellectual property supporting Magtein magnesium L-threonate is strong. We stand ready to protect our intellectual property.”
The terms of the settlement are confidential.
Magtein magnesium L-threonate is a world-class branded ingredient in the dietary supplement industry, with clinical studies to support memory, focus, deep sleep and overall brain health.
ThreoTech, LLC is the exclusive licensee of a wide portfolio of patents owned by Neurocentria Inc. For additional information please contact ThreoTech.
Looking for a reprint of this article?
From high-res PDFs to custom plaques, order your copy today!
